Top Sell
| Wertpapier | Buy ▼ | Sell | Buy (1M) | Sell (1M) | Kurs | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| Natural Alternat. | 19 | 1 | 0 | 0 | 4,74 € | - | - |
| Cara Therapeutics Inc. | 10 | 6 | 0 | 2 | 0,32 € | 4,61 € | 1330,50 % |
| Syros Pharmaceuticals Inc. | 9 | 1 | 3 | 0 | 1,51 € | 12,01 € | 695,07 % |
| Karyopharm Therapeutics Inc. | 8 | 1 | 3 | 0 | 0,69 € | 5,49 € | 691,58 % |
| Bluebird Bio Inc. | 7 | 6 | 3 | 0 | 0,51 € | 5,47 € | 976,37 % |
| Bristol-Myers Squibb | 7 | 3 | 0 | 1 | 45,21 € | 67,64 € | 49,63 % |
| Gritstone Oncology Inc | 6 | 1 | 2 | 0 | 0,43 € | 3,68 € | 747,92 % |
| Viking Therapeutics Inc | 5 | 1 | 0 | 1 | 58,02 € | - | - |
| Sage Therapeutics Inc. | 5 | 2 | 0 | 0 | 7,63 € | 21,44 € | 180,83 % |
| Cellectar BioSciences Inc. | 5 | 4 | 0 | 0 | 1,98 € | 11,09 € | 460,18 % |
| Agenus Inc. | 4 | 2 | 1 | 0 | 0,41 € | 37,02 € | 8846,83 % |
| Fate Therapeutics Inc. | 4 | 3 | 1 | 0 | 3,22 € | 7,31 € | 127,38 % |
| Moleculin Biotech Inc | 3 | 25 | 0 | 2 | 0,41 € | 18,42 € | 4393,66 % |
| Glycomimetics Inc. | 3 | 6 | 0 | 3 | 0,15 € | 9,13 € | 5909,61 % |
| Inotiv Inc. | 3 | 1 | 0 | 0 | 1,26 € | 10,66 € | 746,17 % |
| Palisade Bio Inc. | 3 | 1 | 0 | 0 | 0,34 € | 21,06 € | 6072,33 % |
| Trevena Inc. | 2 | 23 | 0 | 3 | 0,15 € | 6,48 € | 4136,60 % |
| Cytomx Therapeutics Inc | 2 | 1 | 0 | 0 | 1,06 € | 50,00 € | 4603,67 % |
| Rocket Pharmaceuticals Inc | 2 | 1 | 0 | 0 | ? | 32,00 € | 87,85 % |
| Larimar Therapeutics Inc. | 2 | 3 | 0 | 0 | 7,15 € | 58,50 € | 718,18 % |
| Atara Biotherapeutics Inc. | 2 | 2 | 0 | 0 | 0,37 € | 3,00 € | 716,55 % |
| Cyclacel Pharmaceuticals Inc. | 2 | 8 | 0 | 0 | 0,22 € | 14,66 € | 6565,59 % |
| Coherus Bioscien. | 1 | 2 | 1 | 0 | 1,25 € | - | - |
| Aspira Womens Health Inc. | 1 | 1 | 1 | 0 | 0,86 € | 4,99 € | 483,91 % |
| Mirati Therapeutics Inc. | 1 | 10 | 0 | 0 | 53,84 € | 78,43 € | 45,67 % |